Dec / 2024Hearing News WatchSound Pharmaceuticals Reports Positive Phase 3 Results for SPI-1005 in Meniere’s DiseaseHHTMDec / 2024Hearing TechnologiesGrason-Stadler Introduces GSI AMTAS UpdatesHHTMNov / 2024Better Hearing ConsumerIt’s That Time of Year Again!Gael HannanDec / 2024This Week in HearingMimi and Knowles Team Up to Personalize Your Listening ExperienceHHTMFind HearingNovember 27, 2024Your Annual Enjoying the Holidays with Hearing Loss Pep TalkShari EbertsHearing EconomicsDecember 9, 2024Ear device patents for October 2024Holly Hosford-DunnHear in Private PracticeDecember 5, 2024Service Dog for the Hard of Hearing: 10 Questions AnsweredHHTMDizziness DepotNovember 4, 2024Diagnostic Assessment of Vestibular Schwannoma/Acoustic NeuromaBrady WorkmanHear The MusicNovember 26, 2024Musical Dissonance Depends On the Context… And the CultureMarshall ChasinPathways Society November 7, 2024November 2024 NeuroAudiology NewsletterHHTMHearing & KidsFebruary 8, 2023Helping Families Keep Technology on Full TimeHHTMHearing TechnologyDecember 3, 2024Grason-Stadler Introduces GSI AMTAS UpdatesHHTMHearing News WatchDecember 10, 2024Sound Pharmaceuticals Reports Positive Phase 3 Results for SPI-1005 in Meniere’s DiseaseHHTM
Dec / 2024Hearing News WatchSound Pharmaceuticals Reports Positive Phase 3 Results for SPI-1005 in Meniere’s DiseaseHHTM
December 10, 2024Sound Pharmaceuticals Reports Positive Phase 3 Results for SPI-1005 in Meniere’s DiseaseHHTM
